Table 1. Patients' characteristics.
| No. | Age | Sex | Sites ofsarcoidosis | Clinical findings | 68Ga-DOTATOC | CMR(T2/LGE) | Clinical follow-up |
|---|---|---|---|---|---|---|---|
| 1 | 47 | F | LN, lung | Palpitations | negative | negative/negative | unremarkable |
| 2 | 54 | F | LN, lung | Bifascicular block, cardiac enzymes, HF, VPB | positive | positive/positive | VT, ICD |
| 3 | 52 | M | LN, lung | Cardiac enzymes, chest pain |
negative | positive/positive | Initiation of corticosteroids |
| 4 | 41 | M | Lung | Palpitations | negative | negative/negative | unremarkable |
| 5 | 52 | F | LN, lung | Palpitations, SOB | negative | negative/negative | unremarkable |
| 6 | 51 | F | LN, lung, nasal sinus, spleen |
Palpitatons, SOB | negative | negative/negative | Initiation of corticosteroids, azathioprine |
| 7 | 75 | M | LN, lung | SOB, palpitations, LAFB | positive | positive/positive | Initiation of corticosteroids, azathioprine |
| 8 | 42 | F | Bone, LN, liver, lung, spleen |
HF, RBBB | positive | positive/positive | VT, cardiogenic shock |
| 9 | 60 | F | - | HF, LBBB | negative | negative/negative | unremarkable |
| 10 | 42 | M | LN, lung, skin | VT | positive | positive/positive | VT, ICD |
| 11 | 55 | F | LN, liver, lung, omentum | HF, LBBB | negative | positive/positive | unremarkable |
| 12 | 65 | M | LN, lung, parotidea, uvea | VPB | positive | positive/positive | unremarkable |
| 13 | 52 | M | LN, lung | Known CS | positive | positive/positive | unremarkable |
| 14 | 71 | F | LN, lung, skin | Known CS | negative | positive/positive | unremarkable |
| 15 | 25 | F | LN, lung | VT, HF | positive | positive/positive | VT, lifevest |
CS = cardiac sarcoidosis, F = female, HF = heart failure, ICD = implantable cardioverter defibrillator, LAFB = left anterior fascicular block, LN = lymph nodes, M = male, RBBB = right bundle branch block, SOB = shortness of breath, VPB = ventricular premature beats, VT = ventricular tachycardia